SynthesisHead and neck pathology2021
Comparative Analysis Between Dentinogenic Ghost Cell Tumor and Ghost Cell Odontogenic Carcinoma: A Systematic Review.
Synthesis in Head and neck pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 42 citations in OpenAlex.
- Evidence from intra-patient progression indicates adenoid ameloblastoma as a phenotypic variant of dentinogenic ghost cell tumor.Virchows Archiv : an international journal of pathology · 2026Article
- Dentinogenic ghost cell tumor: Two case reports and review of the literature.Dental research journal · 2026Article
- Ghost Cell Odontogenic Carcinoma: Case Series and Literature Review.Head and neck pathology · 2025Review
- Biological Characterization of Odontogenic Ghost Cell Lesions: A Clinicopathological, Immunohistochemical and Molecular Study of a Unicentric Series of 69 Cases.Head and neck pathology · 2025Article
- Dentinogenic ghost cell tumor in a pediatric patient: A case report and literature review.Medicine · 2025Review
- Article
- Dentinogenic Ghost Cell Tumor in an Elderly Female: A Rare Case Report.Case reports in dentistry · 2025Article
- Ameloblastoma with adenoid features with multiple local recurrences: report of a case with clinicopathologic and immunohistochemical studies.International journal of clinical and experimental pathology · 2025Article
- Pediatric dentinogenic ghost cell tumor: a case report and review of the literature.Frontiers in oncology · 2025Article
- Morphological Features of the Spectrum of Ghost Cell Odontogenic Lesions.Head and neck pathology · 2024Article
- Article
- Odontogenic carcinoma with dentinoid: case report and literature review of a rare entity.BMC oral health · 2024Review
- Challenging pitfalls in frozen section pathology: a case of mandible ghost cell odontogenic carcinoma and the literature review.BMC oral health · 2024Article
- Odontogenic Carcinosarcoma: Clinicopathologic and Molecular Features of Three Cases, a Literature Review and Nomenclature Proposal.Head and neck pathology · 2023Review
- Adenoid Ameloblastoma Versus Dentinogenic Ghost Cell Tumor.Head and neck pathology · 2023Review
- Case report: Ghost cell odontogenic carcinoma in a dog: diagnostics and surgical outcome.Frontiers in veterinary science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dentinogenic ghost cell tumor (DGCT) and ghost cell odontogenic carcinoma (GCOC) form a spectrum of rare benign and malignant odontogenic neoplasms, respectively. The aim of this study was to perform a comparative systematic review of the clinicopathological, genetic, therapeutic, and prognostic features of DGCT and GCOC. The electronic search was performed until December 2020 on seven electronic databases. Case reports, series, and research studies with enough histopathological criteria for diagnosis and all genomic studies were included. Both DGCT and GCOC showed a male prevalence (p = 0.043), with mandibular and maxillary predilections, respectively (p = 0.008). Peripheral DGCT (DGCTp) affected most elderly people (p < 0.001), and central DGCT (DGCTc) and GCOC occurred mainly in younger individuals. Unilateral enlargement of maxilla or mandible was the most common clinical sign associated with a radiolucent or mixed image. Ameloblastomatous epithelium was often present in both neoplasms. Basaloid and large cells with vesicular nuclei were also frequently seen in GCOC. β-catenin expression and mutations (CTNNB1 gene) were found in DGCT and GCOC. Conservative surgery was mostly used for DGCTp, while radical resection was chosen for DGCTc and GCOC. High recurrence rates were found in DGCTc and GCOC. Metastasis occurred in 16.7% of GCOC cases and the 5-year survival rate was 72.6%. DGCT and GCOC share numerous clinicopathological features and demand a careful histopathological evaluation, considering the overlap features with other odontogenic tumors and the possibility of malignant transformation of DGCT. A strict regular post-operative follow-up is mandatory due to high recurrence rates and metastatic capacity in GCOC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.